- Home
- DAN vs VRDN Comparison
DAN vs VRDN Comparison
Compare DAN & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAN | VRDN |
|---|---|---|
| Founded | 1904 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.7B |
| IPO Year | 1998 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DAN | VRDN |
|---|---|---|
| Price | $31.39 | $28.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | $35.00 | ★ $40.92 |
| AVG Volume (30 Days) | ★ 1.4M | 1.0M |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | ★ 264.10 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $7,500,000,000.00 | $5,706,000.00 |
| Revenue This Year | $1.92 | $4.67 |
| Revenue Next Year | $3.60 | $331.57 |
| P/E Ratio | $49.77 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.11 | $9.90 |
| 52 Week High | $36.28 | $34.29 |
Technical Indicators
Market Signals| Indicator | DAN | VRDN |
|---|---|---|
| Relative Strength Index (RSI) | 43.09 | 45.38 |
| Support Level | $28.30 | $26.31 |
| Resistance Level | $31.73 | $33.71 |
| Average True Range (ATR) | 1.25 | 1.58 |
| MACD | -0.58 | 0.04 |
| Stochastic Oscillator | 12.13 | 52.01 |
Price Performance
Historical ComparisonAbout DAN Dana Incorporated
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).